Delivery Order SPE2DB22D9316-SPE2DB25FYP24
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,697.06 by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Nplate 500 microgram vials. This firm fixed-price delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,347.34 by the Defense Logistics Agency on July 31, 2025, for the supply of Nplate 250 microgram vials. The delivery order carries an ultimate completion date of August 21, 2025, and requires performance at the contractor's Park Ridge, Illinois facility. This award was issued without a set-aside designation, allowing DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,697.06 by the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of Nplate 500 microgram vials. The contract does not utilize a set-aside designation and carries an ultimate completion date of September 3, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,366.20 by the Defense Logistics Agency on September 2, 2025, for the supply of Nplate 125 microgram vials. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and extending through November 2026. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 10, 2025, for the supply of Nplate 250 microgram vials. The contract, valued at $16,736.70, carries a firm fixed-price structure with an ultimate completion date of October 1, 2025. This delivery order was issued without a set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain division, reflecting...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $33.5K for 500 microgram vials of Nplate by the Defense Logistics Agency's Medical Supply Chain. The award, issued on September 9, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 30, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,366.20 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Nplate 125 microgram vials. This firm fixed-price delivery order, which carries an ultimate completion date of September 23, 2025, is issued without a set-aside designation and represents a continuation of the company's substantial partnership with DLA....
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nplate 250 microgram vials. This $1,673.67 firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes no set-aside designation and is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under...
- The Defense Logistics Agency awarded a delivery order valued at $21,681.63 to DMS Pharmaceutical Group Inc. for the supply of Nplate 250 microgram vials. The award, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, utilizes a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its location in Park...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,736.70 by the Defense Logistics Agency on October 20, 2025, for the supply of Nplate 250 mcg vials. This firm fixed-price delivery order, with an ultimate completion date of November 10, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB25FYP24Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $13,389.36 by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of Nplate 250 micrograms vials. The contract represents a firm fixed-price delivery order with an ultimate completion date of June 24, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide. Nplate is a thrombopoietin receptor agonist used to treat thrombocytopenia in patients with chronic immune thrombocytopenia, reflecting the specialized pharmaceutical supply needs of the Department of Defense healthcare system. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently securing delivery orders from the DLA for diverse medical products including prescription medications, biologics, vaccines, and specialty pharmaceutical items. The company's performance under its master IDC contract demonstrates the DLA's confidence in DMS Pharmaceutical Group's ability to efficiently distribute essential medications and medical supplies to military treatment facilities across the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 6/2/25 |